SomnoMed (SOM.AX) Earnings Analysis

SomnoMed (SOM.AX) next reports earnings on 2026-08-27, consensus EPS -0.004 AUD. Last quarter (2026-02-26) it beat with EPS 0.36 AUD vs 0.3 AUD est (+20%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -38.84.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SOM.AX next report earnings?

Next earnings date2026-08-27
Consensus EPS estimate-0.004 AUD
Revenue estimate0.06B

SOM.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-260.36 AUD0.3 AUD+20%Beat
2025-02-26-0.0005 AUD0.001 AUD-150%Miss
2024-10-23-0.04881 AUD-0.003 AUD-1527%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

SOM.AX valuation and analyst view

Trailing P/E-38.84
Trailing EPS-0.0118 AUD
Price / book2.04
Dividend yield0.00%
Market cap0.10B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is SomnoMed (SOM.AX)'s next earnings date?

SomnoMed is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -0.004 AUD and revenue estimate of 0.06B.

Did SOM.AX beat earnings last quarter?

In its 2026-02-26 report, SOM.AX posted EPS of 0.36 AUD versus a 0.3 AUD estimate — a beat of 20%.

What is SOM.AX's earnings track record?

Over the last 3 reported quarters with consensus data, SOM.AX beat estimates 1 times (33%).

What is SOM.AX's current P/E ratio and EPS?

SOM.AX trades at a trailing P/E of -38.84 on trailing EPS of -0.011800105672835902 AUD.

What do analysts rate SOM.AX?

SOM.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.